Published in Neuropsychopharmacology on January 02, 2013
Sites of action of sleep and wake drugs: insights from model organisms. Curr Opin Neurobiol (2013) 0.85
Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol (2015) 0.84
Impact of Astroglial Connexins on Modafinil Pharmacological Properties. Sleep (2016) 0.83
Histaminergic system in brain disorders: lessons from the translational approach and future perspectives. Ann Gen Psychiatry (2014) 0.79
Loss of Melanopsin Photoreception and Antagonism of the Histamine H3 Receptor by Ciproxifan Inhibit Light-Induced Sleep in Mice. PLoS One (2015) 0.76
Genetic Analysis of Histamine Signaling in Larval Zebrafish Sleep. eNeuro (2017) 0.75
Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B. Sci Rep (2017) 0.75
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease. Pharmacol Res Perspect (2017) 0.75
Impact of sleep debt on metabolic and endocrine function. Lancet (1999) 14.89
Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med (2004) 12.71
The self-tuning neuron: synaptic scaling of excitatory synapses. Cell (2008) 7.06
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature (1983) 4.24
Histamine in the nervous system. Physiol Rev (2008) 3.47
Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol (1992) 3.01
From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci (2005) 2.59
The physiology of brain histamine. Prog Neurobiol (2001) 2.45
Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci (2009) 2.35
Histaminergic transmission in the mammalian brain. Physiol Rev (1991) 2.28
Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci (2002) 2.10
Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature (1978) 1.88
Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res (1984) 1.80
Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci (2006) 1.65
Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci U S A (1984) 1.63
The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol (2008) 1.49
Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci U S A (1996) 1.43
Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther (1998) 1.38
Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal. J Neurosci (1991) 1.31
Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology (1988) 1.29
Histamine and its receptors modulate temperature-preference behaviors in Drosophila. J Neurosci (2006) 1.27
The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci (2004) 1.27
Behavioral characterization of mice lacking histamine H(3) receptors. Mol Pharmacol (2002) 1.26
Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev (2000) 1.26
Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes (2004) 1.25
Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem (1980) 1.21
The sleep-waking cycle. Ergeb Physiol (1972) 1.18
Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci (1996) 1.16
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis (2007) 1.15
Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. Behav Brain Res (2003) 1.11
Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol (2007) 1.11
The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol (2007) 1.10
Anxiety and cognition in histamine H3 receptor-/- mice. Eur J Neurosci (2004) 1.07
Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol (2004) 1.03
Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Res (1990) 1.02
Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol (2006) 1.01
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J Pharmacol Exp Ther (2006) 1.01
Involvement of histamine in the control of the waking state. Life Sci (1993) 1.00
Histamine H3 receptors and sleep-wake regulation. J Pharmacol Exp Ther (2010) 0.98
Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest (2002) 0.94
[Genetic factors as determinants of the waking-sleep cycle in the mouse (author's transl)]. Brain Res (1974) 0.93
Modulation of hippocampal theta oscillation by histamine H3 receptors. J Pharmacol Exp Ther (2007) 0.92
The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity. Trends Pharmacol Sci (2006) 0.90
Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacology (2011) 0.89
Circadian rhythms in behavior and clock gene expressions in the brain of mice lacking histidine decarboxylase. Brain Res Mol Brain Res (2004) 0.89
Effect of alpha-fluoromethylhistidine, a suicide inhibitor of histidine decarboxylase, on histamine levels in mouse tissues. Biochem Pharmacol (1982) 0.89
Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice. Br J Pharmacol (2009) 0.88
[Long-term recording of cerebral, muscular and ocular electric activities in mice]. C R Seances Soc Biol Fil (1971) 0.86
The waking brain: an update. Cell Mol Life Sci (2011) 0.86
Effects of alpha-fluoromethylhistidine on sleep-waking parameters in rats. Physiol Behav (1985) 0.84
Rodent models of insomnia: a review of experimental procedures that induce sleep disturbances. Neurosci Biobehav Rev (2009) 0.83
Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders. J Pharmacol Sci (2006) 0.80
Effects of a-fluoromethylhistidine on sleep and wakefulness in the rat. Short note. J Neural Transm (1988) 0.79
Histaminergic system in the cat hypothalamus with reference to type B monoamine oxidase. J Comp Neurol (1993) 0.78
[Histamine-immunoreactive neurons in the hypothalamus of cats]. C R Acad Sci III (1986) 0.77
Visualization of histamine H1 receptors in dog brain by positron emission tomography. Neurosci Lett (1990) 0.76
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther (2010) 5.24
Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol (2006) 4.07
Genome-wide patterns of genetic variation among elite maize inbred lines. Nat Genet (2010) 4.06
Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem (2005) 3.06
Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol (2008) 3.03
MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. Cancer Biol Ther (2010) 2.68
Genome-wide genetic changes during modern breeding of maize. Nat Genet (2012) 2.60
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents. Mol Cancer Ther (2009) 2.50
Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem (2003) 2.36
Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci (2009) 2.35
Exercise prevents maternal high-fat diet-induced hypermethylation of the Pgc-1α gene and age-dependent metabolic dysfunction in the offspring. Diabetes (2014) 2.24
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. Arthritis Rheum (2011) 2.21
Giant-stroke, superelastic carbon nanotube aerogel muscles. Science (2009) 2.19
Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem (2002) 2.17
Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci (2002) 2.10
Reduction in asthma-related emergency department visits after implementation of a smoke-free law. J Allergy Clin Immunol (2008) 2.02
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A (2011) 2.01
Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.99
Incomplete arousal processes in infants who were victims of sudden death. Am J Respir Crit Care Med (2003) 1.82
PGC-1alpha plays a functional role in exercise-induced mitochondrial biogenesis and angiogenesis but not fiber-type transformation in mouse skeletal muscle. Am J Physiol Cell Physiol (2009) 1.72
Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci (2006) 1.65
Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis Rheum (2010) 1.56
Effect of adiponectin overexpression on stability of preexisting plaques by inducing prolyl-4-hydroxylase expression. Circ J (2010) 1.54
KCNQ1 and KCNE1 in the IKs channel complex make state-dependent contacts in their extracellular domains. J Gen Physiol (2008) 1.52
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2. Int J Cancer (2004) 1.52
Changes in integrin expression during adipocyte differentiation. Cell Metab (2005) 1.51
Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res (2006) 1.50
MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. Mol Cancer Ther (2010) 1.48
Structural and functional role of the extracellular s5-p linker in the HERG potassium channel. J Gen Physiol (2002) 1.46
Usefulness of high-frequency vascular ultrasound imaging and serum inflammatory markers to predict plaque rupture in patients with stable and unstable angina pectoris. Am J Cardiol (2007) 1.46
Characterization of an LQT5-related mutation in KCNE1, Y81C: implications for a role of KCNE1 cytoplasmic domain in IKs channel function. Heart Rhythm (2006) 1.45
Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med (2010) 1.43
Plaque volume compression ratio, a novel biomechanical index, is independently associated with ischemic cerebrovascular events. J Hypertens (2009) 1.41
p38gamma mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice. PLoS One (2009) 1.41
Stimulation of P2X7 receptors elevates Ca2+ and kills retinal ganglion cells. Invest Ophthalmol Vis Sci (2005) 1.40
Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain (2013) 1.39
Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. Gastroenterology (2013) 1.38
Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol (2007) 1.36
A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease. Genes Dev (2007) 1.32
Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells. Cancer Res (2006) 1.32
Drinking behaviour among men and women in China: the 2007 China Chronic Disease and Risk Factor Surveillance. Addiction (2011) 1.31
Smoke-free laws and adult smoking prevalence. Prev Med (2008) 1.30
Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice. Am J Pathol (2007) 1.29
KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased hearts. Circulation (2004) 1.29
A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav Immun (2007) 1.28
The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci (2004) 1.27
The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. J Biol Inorg Chem (2003) 1.25
Effects of a smoke-free law on hair nicotine and respiratory symptoms of restaurant and bar workers. J Occup Environ Med (2006) 1.25
Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther (2008) 1.24
Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health (2011) 1.24
Rabbit knee model of post-traumatic joint contractures: the long-term natural history of motion loss and myofibroblasts. J Orthop Res (2004) 1.24
Reciprocity between abscisic acid and ethylene at the onset of berry ripening and after harvest. BMC Plant Biol (2010) 1.23
Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochem Biophys Res Commun (2009) 1.23
GDE2 promotes neurogenesis by glycosylphosphatidylinositol-anchor cleavage of RECK. Science (2013) 1.23
Negative charges in the transmembrane domains of the HERG K channel are involved in the activation- and deactivation-gating processes. J Gen Physiol (2003) 1.21
KCNE2 is colocalized with KCNQ1 and KCNE1 in cardiac myocytes and may function as a negative modulator of I(Ks) current amplitude in the heart. Heart Rhythm (2006) 1.20
Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology (2013) 1.19
The stomatin/prohibitin/flotillin/HflK/C domain of flotillin-1 contains distinct sequences that direct plasma membrane localization and protein interactions in 3T3-L1 adipocytes. J Biol Chem (2005) 1.18
[Prevalence of hypertension among Chinese adults in 2010]. Zhonghua Yu Fang Yi Xue Za Zhi (2012) 1.17
Autophagy is required for exercise training-induced skeletal muscle adaptation and improvement of physical performance. FASEB J (2013) 1.17
Suppression of 9-cis-epoxycarotenoid dioxygenase, which encodes a key enzyme in abscisic acid biosynthesis, alters fruit texture in transgenic tomato. Plant Physiol (2011) 1.17
Testing an intervention to promote children's adherence to asthma self-management. J Nurs Scholarsh (2007) 1.16
High rate of joint capsule matrix turnover in chronic human elbow contractures. Clin Orthop Relat Res (2005) 1.16
Robust cell migration and neuronal growth on pristine carbon nanotube sheets and yarns. J Biomater Sci Polym Ed (2007) 1.16
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis (2007) 1.15
Myofibroblast numbers are elevated in human elbow capsules after trauma. Clin Orthop Relat Res (2004) 1.14
Mapping the binding site of a human ether-a-go-go-related gene-specific peptide toxin (ErgTx) to the channel's outer vestibule. J Biol Chem (2002) 1.13
Sign Change of Poisson's Ratio for Carbon Nanotube Sheets. Science (2008) 1.12
Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo. Exp Eye Res (2010) 1.12
A sperm-associated WD repeat protein orthologous to Chlamydomonas PF20 associates with Spag6, the mammalian orthologue of Chlamydomonas PF16. Mol Cell Biol (2002) 1.12
[Prevalence and characteristic of overweight and obesity among adults in China, 2010]. Zhonghua Yu Fang Yi Xue Za Zhi (2012) 1.12
Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol (2007) 1.11
Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor. Mol Cancer (2009) 1.11
Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli. PLoS One (2008) 1.10
Dynamic partnership between KCNQ1 and KCNE1 and influence on cardiac IKs current amplitude by KCNE2. J Biol Chem (2009) 1.10
Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc Natl Acad Sci U S A (2007) 1.09
Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat Immunol (2005) 1.09
Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization. Invest Ophthalmol Vis Sci (2005) 1.09
Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha. Endocrinology (2002) 1.09
Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. J Invest Dermatol (2008) 1.08
Dynamic conformational changes of extracellular S5-P linkers in the hERG channel. J Physiol (2005) 1.07
Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol (2015) 1.06
ATG5 regulates plasma cell differentiation. Autophagy (2013) 1.06
Risk factors for noncommunicable chronic diseases in women in China: surveillance efforts. Bull World Health Organ (2013) 1.06
Mechanical stretch modulates microRNA 21 expression, participating in proliferation and apoptosis in cultured human aortic smooth muscle cells. PLoS One (2012) 1.05
Adiponectin inhibits lipopolysaccharide-induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway. Mol Endocrinol (2009) 1.05
The Mark Coventry Award: Higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trial. Clin Orthop Relat Res (2014) 1.05
A novel MitoTimer reporter gene for mitochondrial content, structure, stress, and damage in vivo. J Biol Chem (2014) 1.05
Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int (2003) 1.04
Protean agonism at histamine H3 receptors in vitro and in vivo. Proc Natl Acad Sci U S A (2003) 1.04
The phosphatidylglycerol/cardiolipin biosynthetic pathway is required for the activation of inositol phosphosphingolipid phospholipase C, Isc1p, during growth of Saccharomyces cerevisiae. J Biol Chem (2004) 1.03
Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation. J Neurochem (2006) 1.03
Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol (2007) 1.03
Co-variations and clustering of chronic disease behavioral risk factors in China: China Chronic Disease and Risk Factor Surveillance, 2007. PLoS One (2012) 1.03
Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otol Neurotol (2011) 1.03
Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape. J Clin Invest (2011) 1.02